Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go:
Expired
investment:
£1,314,967
Publisher Discovery, using AI & Machine Learning technologies, provides recommendations to Advertisers of highly relevant Publishers in the affiliate marketing sector. The company has built a uniquely curated database of over 2 million publishers and 330,000 advertisers, which are then analysed, compared, and matched to make recommendations in ranked lists, matching the best publishers with each advertiser. The affiliate publishing market is worth 16 billion dollars per year but is still largely dominated by human-based agencies and is uniquely suited for automation. Publisher Discovery aims to capitalise on this aspect and establish itself as the market leader. The company has signed up over 50 publishers and is negotiating contracts with two large distribution partners. It is currently raising £1 million investment with £675,000 committed so far, to grow sales and operations and reach over £2m Annual Recurring Revenue (ARR) in the following 12 months.
days to go:
Expired
investment:
£800,000
Zoom 1hr is a hyperlocal last-mile delivery service delivering food, convenience and retail goods within one hour. The company is currently operating in West Midlands, Wales, and bordering English counties. It aims to become a contender in the online food delivery market that is projected to reach over £5 billion in 2021. Zoom 1hr has witnessed 70,000 app downloads, processed over 280,000 orders through its platform, and gained an annual turnover of £665,000 in 2019-2020 at an order growth rate of 108%. Zoom 1hr argues that its list of partners consists of local, national and international stores including Subway and KFC. It has also secured a contract with Co-Op to be its third national last-mile delivery partner, currently servicing 61 stores. The company will use the investment for New Area Mobilisation (NAM), product and website development, key hires, and team expansion.
days to go:
Expired
investment:
£595,084
SquareBook is a tech platform revolutionizing equity fundraising by providing companies with an efficient and digital solution for capital raises, from private deals to IPOs and secondaries. They offer rule-based auctions, bringing together companies, advisors, and investors in one place, and generate revenue through monthly subscription fees and transaction fees, offering a cost-effective alternative to traditional investment banking fees for capital raising.
days to go:
Expired
investment:
£515,770
UnderPinned gives freelancers a single, dedicated platform to learn how to build a successful business, find clients, manage their work, and help them get paid on time. The company aspires to build a connection with users that ensures everyone thrives through its accelerator programme, community, and content. UnderPinned asserts that its accelerator programme allows it to achieve day one unit profitability before converting users to subscribers. It claims to have made £12,772 in revenue with £8,000 spent on marketing in its first month of programme sales in January 2021. The company argues that COVID-19 has accelerated freelancing, moving away from traditional employment. UnderPinned has a community of over 20,000 subscribers and growing. It says itvwill use the investment to scale its team, marketing and product development as it focuses on expanding in the US and EU markets.
days to go:
Expired
investment:
£629,086
Plum helps users save money, invest and not overpay bills using an AI-enabled financial butler. Plum links to your bank account and using a smart algorithm driven by AI identifies opportunities to save small amounts of money and ensures you are not overpaying your bills by suggesting cheaper alternatives.
days to go:
Expired
investment:
£923,255
Untied is a groundbreaking app that gathers information, claims costs and allowances, and prepares tax filings on the go. All of these can be sent to the tax authority from the application. The app connects across existing accounts, making tax sense of transactions and gives the assurance someone needs. Backed by Accenture's Fintech Innovation Lab and Barclays Techstars, the company became the first overseas winner of Israel's biggest fintech prize at Fintech Junction. The business will earn a turn over of £100m in ten years making it ready for an IPO. With the proceeds, it will create new software platforms, publishers, banks, and accounting firms.
days to go:
Expired
investment:
£350,000
CrowdToLive is a Financial Conduct Authority (FCA) regulated financial technology company that seeks to revolutionise residential property financing and investment. It claims that 4 out of 10 young homeowners in the UK have had their mortgage applications rejected. CrowdToLive intends to change this by facilitating a circular flow of finance between buy to let investors and the homebuyers. It argues that its platform allows buyers to own their homes without incurring debt and lets investors reap the rewards of the housing market without the hassle of tenant management. The company claims it has built a community of over 7,000 users, submitted over 2,600 properties for a value of circa GBP 600 million, and is a part of accelerator programmes such as Virgin Start-Up Accelerator Programme and Barclays Eagle Lab Accelerator Programme. CrowdToLive intends to use 10% of the investment to support international expansion, 15% towards business development, 40% towards hiring key personnel, 25% towards upgrading its IT infrastructure, and 10% towards marketing.
days to go:
Expired
investment:
£339,744
Nexus is a digital platform that empowers users to take control of their health and wellbeing. It states that long-term health conditions like diabetes and cancer will account for over 50% of global health spending by the end of 2021 with depression becoming the leading cause of disability. Nexus aims to address this situation via its app. It argues that its app will offer users health coaching, telemental health, products, and services to transform their lifestyle. Nexus claims that the app can track progress via self-entered user data and is being designed to connect with apps and wearables to inspire life-long behavioural change. Nexus has prepared a pilot for an NHS Trust endorsed by Boston Scientific with a collaboration agreement to roll out the app to 30,000 NHS users. Nexus was one of 100 startups chosen to pitch at the World Business Angels Forum 2020. The Company says that it will use the investment to support Phase 2 of its tech build, grow further in the UK, and start its expansion in the UAE.
days to go:
Expired
investment:
£280,360
EMERGEiQ is a cloud-based platform targeted towards Small and Medium Enterprises (SMEs) and large corporate organisations. The company plans on having an extensive suite of algorithms that simplifies Data Science (DS) and Artificial Intelligence (AI) at low cost, across all sectors. EMERGEiQ asserts that its analytics can help businesses improve operational productivity, cut costs, and eventually generate more revenue. It has worked with companies across a variety of sectors such as finance, medicine, stock market, and insurance. The company will use will 30% of the investment for R&D, 25% to purchase software and hardware to improve platform capabilities, 25% to market its new product line, 10% as working capital, and 10% as miscellaneous expenses.
days to go:
Expired
investment:
£150,000
